Addresses microbially derived commercially important bioactive products that are currently or soon-to-be available. This second edition includes analyses of the use of recombinant enzymes to produce biologically active molecules; insights into the biochemistry, molecular biology and production of antibiotics used as therapeutic agents; and a focuses of state-of-the art techniques for the development of new antibiotics using novel approaches and strategies.